The estimated Net Worth of Jeffrey S. Points is at least 3.45 百万$ dollars as of 20 May 2022. Mr. Points owns over 3,000 units of Cardiovascular Systems stock worth over 2,186,240$ and over the last 7 years he sold CSII stock worth over 171,356$. In addition, he makes 1,095,460$ as Chief Financial Officer at Cardiovascular Systems.
Sign up
Mr. Points CSII stock SEC Form 4 insiders trading
Jeffrey has made over 7 trades of the Cardiovascular Systems stock since 2018, according to the Form 4 filled with the SEC. Most recently he bought 3,000 units of CSII stock worth 43,500$ on 20 May 2022.
The largest trade he's ever made was buying 3,000 units of Cardiovascular Systems stock on 20 May 2022 worth over 43,500$. On average, Jeffrey trades about 402 units every 52 days since 2018. As of 20 May 2022 he still owns at least 109,312 units of Cardiovascular Systems stock.
You can see the complete history of Mr. Points stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Jeffrey Points biography
Jeffrey Points is Chief Financial Officer of the company. Mr. Points joined us in September 2007 as Corporate Controller, became Senior Director and Controller in July 2013, Corporate Controller and Treasurer in January 2015, Vice President, Corporate Controller and Treasurer in May 2017 and was promoted to Chief Financial Officer in February 2018. From July 2005 to September 2007, Mr. Points was Assistant Controller at Empi, a manufacturer and provider of non-invasive medical products for pain management and physical rehabilitation. From January 1998 to July 2005, Mr. Points held various leadership positions at CliftonLarsonAllen, a national public accounting firm. Mr. Points also serves as a member of the board of directors for The Phoenix Residence, Inc.
What is the salary of Jeffrey Points?
As the Chief Financial Officer of Cardiovascular Systems, the total compensation of Jeffrey Points at Cardiovascular Systems is 1,095,460$. There are 4 executives at Cardiovascular Systems getting paid more, with Scott Ward having the highest compensation of 4,718,960$.
How old is Jeffrey Points?
Jeffrey Points is 43, he's been the Chief Financial Officer of Cardiovascular Systems since 2018. There are 23 older and 2 younger executives at Cardiovascular Systems. The oldest executive at Cardiovascular Systems Inc. is Augustine Lawlor, 64, who is the Independent Director.
What's Jeffrey Points's mailing address?
Jeffrey's mailing address filed with the SEC is 1225 OLD HIGHWAY 8 NW, , ST. PAUL, MN, 55112.
Insiders trading at Cardiovascular Systems
Over the last 16 years, insiders at Cardiovascular Systems have traded over 72,999,461$ worth of Cardiovascular Systems stock and bought 949,532 units worth 8,687,068$ . The most active insiders traders include Capital Management Lp Camber、Augustine Lawlor、Capital Ltdmaverick Capital.... On average, Cardiovascular Systems executives and independent directors trade stock every 14 days with the average trade being worth of 338,920$. The most recent stock trade was executed by Martha Goldberg Aronson on 15 August 2022, trading 2,411 units of CSII stock currently worth 48,220$.
What does Cardiovascular Systems do?
Cardiovascular Systems, Inc., based in St. Paul, Minn., is a medical device company focused on developing and commercializing innovative solutions for treating vascular and coronary disease. The company's orbital atherectomy system treats calcified and fibrotic plaque in arterial vessels throughout the leg and heart and addresses many of the limitations associated with existing surgical, catheter and pharmacological treatment alternatives.
What does Cardiovascular Systems's logo look like?
Complete history of Mr. Points stock trades at Cardiovascular Systems
Cardiovascular Systems executives and stock owners
Cardiovascular Systems executives and other stock owners filed with the SEC include:
-
Scott Ward,
Chairman of the Board, President, Chief Executive Officer -
Rhonda Robb,
Chief Operating Officer -
Scott Raymond Ward B.Sc., M.S., MS,
Chairman, Pres & CEO -
Scott Raymond Ward M.S., MS, B.Sc.,
Chairman, Pres & CEO -
Jeffrey Points,
Chief Financial Officer -
Alexander Rosenstein,
General Counsel and Corporate Secretary -
Ryan Egeland,
Chief Medical Officer -
Rhonda J. Robb,
Chief Operating Officer -
Sandra Sedo,
Chief Compliance Officer -
Jeffrey S. Points,
Chief Financial Officer -
Alexander Rosenstein,
Gen. Counsel & Corp. Sec. -
Dr. Ryan D. Egeland M.D., Ph.D.,
Chief Medical Officer -
Edward Brown,
Independent Director -
Augustine Lawlor,
Independent Director -
Martha Aronson,
Independent Director -
Erik Paulsen,
Independent Director -
William Cohn,
Independent Director -
Stephen Stenbeck,
Independent Director -
Stephen Rempe,
Chief Human Resource Officer -
Kelvin Womack,
Independent Director -
David Whitescarver,
Vice President - Corporate Development and Intellectual Property -
John Hastings,
Vice President - Manufacturing and Operations -
Stephen J. Rempe,
Chief HR Officer -
David S. Whitescarver,
VP of Corp. Devel. & Intellectual Property -
Sandra M. Sedo,
Chief Compliance Officer -
John M. Hastings,
Exec. VP of Operations & Technology -
John E. Nielsen,
VP of Investor Relations & Corp. Communications -
Brent G Blackey,
Director -
Leslie Trigg,
Director -
Capital Management Lp Camber,
10% owner -
Scott A Bartos,
Director -
Laurence L Betterley,
Chief Financial Officer -
Kevin J. Kenny,
Chief Operating Officer -
Laura Gillund,
Chief Talent Officer -
Sachin H. Jain,
Director -
Capital Ltdmaverick Capital...,
-
Gary M Petrucci,
Director -
Paul A. Koehn,
SVP Quality & Operations -
James E Flaherty,
Chief Administrative Officer -
Glen D Nelson,
Director -
Robert J Thatcher,
Executive VP -
David Martin,
President and CEO -
Geoffrey O Hartzler,
Director -
Brian Doughty,
VP of Marketing -
Paul A Tyska,
VP of Business Dev -
Roger J Howe,
Director -
Group I, Llc Donoghue Danie...,
-
John H Friedman,
Director -
Scott William Kraus,
VP Sales -
Advisors, Inc Bonderman Dav...,
-
Geoffrey M Duyk,